|
Volumn 29, Issue 4, 2000, Pages 419-420
|
Orlistat (Xenical) in the management of obesity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
AMPHETAMINE DERIVATIVE;
DEXFENFLURAMINE;
FENFLURAMINE;
FLUOXETINE;
MAZINDOL;
PHENTERMINE;
SEROTONIN AGONIST;
TETRAHYDROLIPSTATIN;
BEHAVIOR THERAPY;
CALORIC RESTRICTION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIFFERENTIAL DIAGNOSIS;
DOUBLE BLIND PROCEDURE;
DRUG CONTRAINDICATION;
DRUG DEPENDENCE;
EDITORIAL;
FLATULENCE;
GASTROINTESTINAL TOXICITY;
HEALTH HAZARD;
HUMAN;
MAJOR CLINICAL STUDY;
OBESITY;
PATHOGENESIS;
PREVALENCE;
PULMONARY HYPERTENSION;
RANDOMIZED CONTROLLED TRIAL;
VALVULAR HEART DISEASE;
|
EID: 0033777092
PISSN: 03044602
EISSN: 29724066
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (5)
|
References (11)
|